Qi Li

Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

In situ generation of dendritic cell vaccines in 3D printing scaffolds for cancer post-surgical therapy.

In situ generation of dendritic cell vaccines in 3D printing scaffolds for cancer post-surgical therapy.

Journal: National science review

Published: September 16, 2025

Role of desmopressin and enuresis alarm in improving sleep quality in children with primary monosymptomatic nocturnal enuresis: A multicentre prospective, randomised study in mainland China.

Role of desmopressin and enuresis alarm in improving sleep quality in children with primary monosymptomatic nocturnal enuresis: A multicentre prospective, randomised study in mainland China.

Journal: Sleep medicine

Published: July 17, 2025

[Retracted] Metformin mitigates PLC? gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration?resistant prostate cancer xenograft models.

[Retracted] Metformin mitigates PLC? gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration?resistant prostate cancer xenograft models.

Journal: Oncology letters

Published: May 22, 2025

Bladder and urethra IgG4-Related sclerosing disease: A case report.

Bladder and urethra IgG4-Related sclerosing disease: A case report.

Journal: Asian journal of surgery

Published: August 01, 2024

Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy.

Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy.

Journal: Journal of nanobiotechnology

Published: March 04, 2024

Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].

Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 11, 2022

Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment.

Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment.

Journal: Cell cycle (Georgetown, Tex.)

Published: November 02, 2021

eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.

eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.

Journal: BMC cancer

Published: February 26, 2021

Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression.

Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression.

Journal: BMC cancer

Published: September 02, 2019

RETRACTED: Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a.

RETRACTED: Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 10, 2018

Low concentration of BPA induces mice spermatocytes apoptosis via GPR30.

Low concentration of BPA induces mice spermatocytes apoptosis via GPR30.

Journal: Oncotarget

Published: December 05, 2016

Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.

Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.

Journal: Experimental cell research

Published: May 14, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026